Navigation Links
Synthetic Genomics Inc. and ExxonMobil Research and Engineering Company Sign Exclusive, Multi-Year Agreement to Develop Next Generation Biofuels Using Photosynthetic Algae
Date:7/14/2009

LA JOLLA, Calif., July 14 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying genomic-driven commercial solutions to address a variety of global challenges including energy and the environment, announced today a multi-year research and development agreement with ExxonMobil Research and Engineering Company (EMRE) to develop next generation biofuels using photosynthetic algae.

As part of the multi-faceted agreement, SGI will receive milestone payments for achievements in developing biofuel products. Total funding for SGI in research and development activities and milestone payments could amount to more than $300 million with the potential for additional income from licensing to third parties.

"This agreement between SGI and EMRE represents a comprehensive, long-term research and development exploration into the most efficient and cost effective organisms and methods to produce next generation algal biofuel," said J. Craig Venter, Founder and CEO of SGI. "We are confident that the combination of our respective expertise in science, research, engineering and scale-up should unlock the power of algae as biological energy producers in methods and scale not previously explored."

Photosynthetic algae, which include microalgae (single celled algae) and cyanobacteria (most commonly known as blue-green algae) are organisms that are very efficient at utilizing the energy from sunlight to convert carbon dioxide into cellular oils (lipids) and even some types of long-chain hydrocarbons that can be further processed into fuels and chemicals. However, naturally-occurring algae do not carry out this process at the efficiencies or rates necessary for commercial-scale production of biofuels.

Using SGI's scientific expertise and proprietary tools and technologies in genomics, metagenomics, synthetic genomics, and genome engineering as a platform, SGI and
'/>"/>

SOURCE Synthetic Genomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
2. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
3. Venter Institute Scientists Create First Synthetic Bacterial Genome
4. ES Vascular Receives CE Mark for its First Aortic Stapler for End-to-End Anastomosis Between Synthetic Grafts and Aorta During Open Repair of Aortic Aneurysmal and Occlusive Disease
5. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
6. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
7. RNAi Helps Illuminate the Inner Workings of the Cell Cycle: Synthetic RNAissance™ Genes Created by DNA2.0 Enable Key Research
8. Synthetic Biology Importance in the 21st Century
9. Synthetic Biology: The Next Biotech Revolution Is Brewing
10. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
11. Synthetic Biology on the Rise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Mat... extract, responds to a press release issued on No...arian company for making false and self-serving st...ences. ,, Dr. Hidvegi stated from his office i...that research on Avemar does not apply to AveULTRA...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewswir...ve filed on November 16th, 2009 Flibanserin in the...skinesia in Parkinson,s,disease for orphan drug st...y,(EMEA). Levodopa-induced dyskinesia is a complic...son,s and a serious burden to some of those,affect...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswir...e program on one product candidate at an unexpecte...ate AD02 is planned to enter into,Phase II clinica...y,immediately follows the completion of two Phase ...mpany based its fast decision on the first interim...
(Date:11/18/2009)...ists at Queen,s University Belfast are developing ...drugs which will help in the fight against the thr... special gel pads to ,swipe, an individual or crim...by a scanning instrument that can detect the prese...etter, faster decisions to be made in response to ...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New technology detects chemical weapons in seconds 2
... Feb. 26 BioVascular, Inc., a company focused,on ...ated diseases, today,announced that it appointed C... vice president of pharmaceutical operations and E...usiness development and nonvascular,operations., ...and experience to,BioVascular that will allow us t...
...Calif., Feb. 26 Ardea Biosciences,Inc. (Nasdaq: ...atory,disease Scientific Advisory Board (SAB). The...d counsel to the Company regarding key decisions,r...o treat chronic,inflammatory diseases, such as gou...ether a group of international authorities in gout...
... Industry Veteran to Head Rapid Sales Growth of Le...ement Developer, SANTA CLARA, Calif., Feb. 26 Ek...l radiography (DR), PACS (Picture Archiving and,Co...are (VIA(TM)) for,veterinary care practices, today...resident of worldwide sales. Royea is a long-time ...
Other Biology Technology:BioVascular, Inc. Expands Executive Team 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 2Ardea Biosciences Establishes Scientific Advisory Board for Inflammation Program 3Royea Joins Eklin Medical Systems as VP of Worldwide Sales 2Royea Joins Eklin Medical Systems as VP of Worldwide Sales 3
(Date:11/20/2009)...hers are invited to contribute their abstracts to ...ECCEO10), the largest global meeting devoted to al...rch and patient care. The Congress will be held in... today, abstracts can be submitted online at http...dline is February 4, 2010. , IOF and ESCEO are p...
(Date:11/20/2009)...y question in the origin of biological molecules l...llions of years ago from simple precursors. Now, i...s in Italy have reconstructed one of the earliest ...RNA from individual subunits using nothing but war...s one of the first biological molecules present, b...
(Date:11/20/2009)...Toxic dust: Toxins in coal-tar-based sealcoats in ...use dust, according to a USGS study. PAHs or pol... found in oil, coal and tar deposits, and can have... often found in house dust; however, the specific ...searchers found that dust from indoor areas near p...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 1Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 2Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2
... To arrange for an interview with a researcher, p...tions staff member identified at the end of each t...and development activities, please refer to one of...elated question or comment, you can send it to ne... . . , Oak Ridge National Laboratory researcher...
... Barcelona, Spain: It is better for children conc...igins at an early age, according to the first larg...or conception. If the children are not told until ... feelings of shock and anger, the 24th annual meet...and Embryology in Barcelona heard today (Monday). ...
... , , ARTICLE #1 FOR IMMEDIATE RELEASE , Boosti... Diabetes, Bioconjugate Chemistry , Researchers...rove the effectiveness and expand the use of trans...s. Their study is scheduled for the July 16 issue ...l. Insulin-dependent, or Type 1, diabetes affects ...
Other Biology News:Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2008 2Story tips from the Department of Energy's Oak Ridge National Laboratory, July 2008 3Children born after donor insemination should be told as soon as possible about their conception 2Children born after donor insemination should be told as soon as possible about their conception 3American Chemical Society's Weekly PressPac -- July 2, 2008 2American Chemical Society's Weekly PressPac -- July 2, 2008 3American Chemical Society's Weekly PressPac -- July 2, 2008 4American Chemical Society's Weekly PressPac -- July 2, 2008 5American Chemical Society's Weekly PressPac -- July 2, 2008 6American Chemical Society's Weekly PressPac -- July 2, 2008 7American Chemical Society's Weekly PressPac -- July 2, 2008 8American Chemical Society's Weekly PressPac -- July 2, 2008 9
Complete 2 channel polarographic oxygen monitoring system from Instech Solomon
XTT (23-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) from Molecular Probes (Invitrogen)
...5) This volume provides excellent background inf...ds for the study of major HIV proteins including: ...uclease H, integrase and protease. Expression of H...s; Tat and Rev assays; HIV/CD4 interactions; trans...
Sheep Anti-Mouse TREM-2 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: